Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes
Trecia A. Wouldes(University of Auckland), Janet Rowan(Auckland City Hospital), Elaine Rush(Auckland University of Technology), William M. Hague(University of Adelaide), Malcolm Battin(University of Auckland), Suzette Coat(The University of Adelaide)
Cited by 109
Related Papers
Metformin versus Insulin for the Treatment of Gestational Diabetes
|New England Journal of Medicine|2008|1.3k
Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
|Diabetes Care|2011|385
Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age
|BMJ Open Diabetes Research & Care|2018|295
An Early Pregnancy HbA1c ≥5.9% (41 mmol/mol) Is Optimal for Detecting Diabetes and Identifies Women at Increased Risk of Adverse Pregnancy Outcomes
|Diabetes Care|2014|239
Is There a Role for HbA1c in Pregnancy?
|Current Diabetes Reports|2016|107